Guardian Pharmacy director sells 671K shares

Guardian Pharmacy Services director and officer Fred Burke reported an open-market sale of 671,432 shares of Class A common stock at an average price of $29.6825 per share.

Rhea-AI Filing Summary

Guardian Pharmacy Services director and officer Fred Burke reported an open-market sale of 671,432 shares of Class A common stock at an average price of $29.6825 per share. The shares were sold pursuant to an underwriting agreement involving the company and other selling stockholders. After this transaction, Burke directly owns 840,413 shares of Guardian Pharmacy Services, Inc.

Insights

Equity analyst

Fred Burke completed a sizable underwritten share sale but retains a substantial direct stake.

Director and officer Fred Burke executed an open-market sale of 671,432 shares of Guardian Pharmacy Services, Inc. Class A common stock at $29.6825 per share. The transaction was carried out under an underwriting agreement alongside other selling stockholders and underwriters BofA Securities and Jefferies.

Following the sale, Burke directly holds 840,413 shares, indicating he still maintains a significant ownership position. Because the transaction was pursuant to a structured underwriting agreement, it appears more like an organized liquidity event than a routine market trade, and its long-term significance depends on the company’s broader capital markets plans.

Insider Trade Summary

Net Seller: 671,432 shares

Net Sell 1 txn

Insider Burke Fred

Role See Remarks

Sold 671,432 shs ($19.93M)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	671,432	$29.6825	$19.93M

Holdings After Transaction: Class A Common Stock — 840,413 shares (Direct)

Footnotes (1)

1. F1. Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated March 18, 2026, by and among the Issuer, the selling stockholders party thereto, and BofA Securities, Inc. and Jefferies LLC, as representatives of the several underwriters named therein.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Guardian Pharmacy (GRDN) report for Fred Burke?

Fred Burke reported selling 671,432 shares of Guardian Pharmacy Services Class A common stock. The sale was an open-market transaction executed at an average price of $29.6825 per share, documented on a Form 4 insider trading report.

At what price did Fred Burke sell Guardian Pharmacy (GRDN) shares?

Fred Burke sold 671,432 Guardian Pharmacy Services Class A shares at an average price of $29.6825 per share. This price reflects the consideration received per share in the reported open-market sale under the underwriting agreement.

How many Guardian Pharmacy (GRDN) shares does Fred Burke hold after the sale?

After the reported transaction, Fred Burke directly owns 840,413 shares of Guardian Pharmacy Services Class A common stock. This post-transaction holding is disclosed in the Form 4 and reflects his remaining direct equity stake in the company.

Was Fred Burke’s Guardian Pharmacy (GRDN) share sale part of an underwriting deal?

Yes. The Form 4 footnote states the sold Class A common stock was transferred pursuant to an underwriting agreement dated March 18, 2026, involving the issuer, certain selling stockholders, and underwriters BofA Securities and Jefferies.

What type of security did Fred Burke trade in Guardian Pharmacy (GRDN)?

Fred Burke traded Guardian Pharmacy Services, Inc. Class A common stock with a par value of $0.001 per share. The Form 4 identifies this as a non-derivative security, meaning it represents direct common equity rather than options or other derivatives.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/24/2026 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burke Fred

(Last) (First) (Middle)

300 GALLERIA PARKWAY SE, SUITE 800

(Street)

ATLANTA GEORGIA 30339

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardian Pharmacy Services, Inc. [ GRDN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/20/2026		S(1)		671,432	D	$29.6825	840,413	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated March 18, 2026, by and among the Issuer, the selling stockholders party thereto, and BofA Securities, Inc. and Jefferies LLC, as representatives of the several underwriters named therein.

Remarks:

President and Chief Executive Officer

	/s/ Douglas Towns, Attorney-in-Fact	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)